1H-MRSI evidence for cortical gray matter pathology that is independent of cerebral white matter lesion load in patients with secondary progressive multiple sclerosis

Journal of the Neurological Sciences

Volumn 282, Issue 1-2, 2009, Pages 72-79

  Caramanos, Zografos ^a   DiMaio, Salvatore ^a   Narayanan, Sridar ^a   Lapierre, Yves ^a   Arnold, Douglas L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cortical grey matter; Cortical lesions; Magnetic resonance imaging; Magnetic resonance spectroscopic imaging; Magnetic resonance spectroscopy; N acetyl aspartate; White matter lesions

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; FEMALE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROIMAGING; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; WHITE MATTER LESION;

ADULT; ANALYSIS OF VARIANCE; BRAIN; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; PROTONS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67349170797     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.01.015     Document Type: Article

References (61)

1. Brownell B., and Hughes J.T. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25 (Nov 1962) 315-320
2. Peterson J.W., and Trapp B.D. Neuropathobiology of multiple sclerosis. Neurol Clin 23 1 (Feb 2005) 107-129 vi-vii
3. Kidd D., Barkhof F., McConnell R., Algra P.R., Allen I.V., and Revesz T. Cortical lesions in multiple sclerosis. Brain 122 Pt 1 (1999 Jan) 17-26
4. Geurts J.J., Bo L., Pouwels P.J., Castelijns J.A., Polman C.H., and Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 26 3 (Mar 2005) 572-577
5. Geurts J.J., Pouwels P.J., Uitdehaag B.M., Polman C.H., Barkhof F., and Castelijns J.A. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236 1 (Jul 2005) 254-260
6. Geurts J.J., Blezer E.L., Vrenken H., van der Toorn A., Castelijns J.A., Polman C.H., et al. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis?. J Neurol 255 2 (Feb 2008) 183-191
7. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 3 (Sep 2001) 389-400
8. Bo L., Vedeler C.A., Nyland H., Trapp B.D., and Mork S.J. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9 4 (Aug 2003) 323-331
9. Calabrese M., De Stefano N., Atzori M., Bernardi V., Mattisi I., Barachino L., et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 64 10 (Oct 2007) 1416-1422
10. Filippi M., Valsasina P., and Rocca M. Magnetic resonance imaging of grey matter damage in people with MS. Int MS J 14 1 (Mar 2007) 12-21
11. Pirko I., Lucchinetti C.F., Sriram S., and Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 68 9 (Feb 27 2007) 634-642
12. Vrenken H., and Geurts J.J. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective. Expert Rev Neurother 7 3 (Mar 2007) 271-279
13. Calabrese M., Filippi M., Rovaris M., Mattisi I., Bernardi V., Atzori M., et al. Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. Neuroimage 42 4 (Oct 1 2008) 1324-1328
14. Geurts J.J., and Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 7 9 (Sep 2008) 841-851
15. Stadelmann C., Albert M., Wegner C., and Bruck W. Cortical pathology in multiple sclerosis. Curr Opin Neurol 21 3 (Jun 2008) 229-234
16. Calabrese M., Filippi M., Rovaris M., Bernardi V., Atzori M., Mattisi I., et al. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Mult Scler 15 1 (Jan 2009) 36-41
17. Lumsden C.E. The neuropathology of multiple sclerosis. In: Vinken P.J., and Bryun Q.W. (Eds). Handbook of clinical neurology Amsterdam (2001), North Holland 217-309
18. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 Pt 11 (Nov 2005) 2705-2712
19. Vercellino M., Plano F., Votta B., Mutani R., Giordana M.T., and Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64 12 (Dec 2005) 1101-1107
20. Wegner C., Esiri M.M., Chance S.A., Palace J., and Matthews P.M. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 67 6 (Sep 26 2006) 960-967
21. Bo L., Geurts J.J., van der Valk P., Polman C., and Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 64 1 (Jan 2007) 76-80
22. van Horssen J., Brink B.P., de Vries H.E., van der Valk P., and Bo L. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 66 4 (Apr 2007) 321-328
23. Gilmore C.P., Donaldson I., Bo L., Owens T., Lowe J.S., and Evangelou N. Regional variations in the extent and pattern of grey matter demyelination in Multiple Sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry (Oct 1 2008)
24. Moll N.M., Rietsch A.M., Ransohoff A.J., Cossoy M.B., Huang D., Eichler F.S., et al. Cortical demyelination in PML and MS: similarities and differences. Neurology 70 5 (Jan 29 2008) 336-343
25. Caramanos Z., Narayanan S., and Arnold D.L. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review. Brain 128 Pt 11 (Nov 2005) 2483-2506
26. Moffett J.R., Namboodiri M.A., Cangro C.B., and Neale J.H. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 2 3 (Mar 1991) 131-134
27. Simmons M.L., Frondoza C.G., and Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45 1 (1991) 37-45
28. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59 1 (Jul 1992) 55-61
29. Bhakoo K.K., and Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74 1 (Jan 2000) 254-262
30. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 5 (Jan 29 1998) 278-285
31. Simon J.H., Jacobs L.D., Campion M.K., Rudick R.A., Cookfair D.L., Herndon R.M., et al. A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 53 1 (Jul 13 1999) 139-148
32. Fu L., Matthews P.M., De Stefano N., Worsley K.J., Narayanan S., Francis G.S., et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121 Pt 1 (Jan 1998) 103-113
33. De Stefano N., Narayanan S., Matthews P.M., Francis G.S., Antel J.P., and Arnold D.L. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 122 Pt 10 (Oct 1999) 1933-1939
34. Arnold D.L., De Stefano N., Narayanan S., and Matthews P.M. Proton MR spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 10 4 (Nov 2000) 789-798 ix-x
35. Sharma R., Narayana P.A., and Wolinsky J.S. Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging. Mult Scler 7 4 (Aug 2001) 221-226
36. Pan J.W., Coyle P.K., Bashir K., Whitaker J.N., Krupp L.B., and Hetherington H.P. Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy. Mult Scler 8 3 (May 2002) 200-206
37. Geurts J.J., Reuling I.E., Vrenken H., Uitdehaag B.M., Polman C.H., Castelijns J.A., et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 55 3 (Mar 2006) 478-483
38. Chard D.T., Griffin C.M., McLean M.A., Kapeller P., Kapoor R., Thompson A.J., et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 125 Pt 10 (Oct 2002) 2342-2352
39. Kapeller P., Brex P.A., Chard D., Dalton C., Griffin C.M., McLean M.A., et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 8 3 (May 2002) 207-210
40. Sarchielli P., Presciutti O., Tarducci R., Gobbi G., Alberti A., Pelliccioli G.P., et al. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol 249 7 (Jul 2002) 902-910
41. Adalsteinsson E., Langer-Gould A., Homer R.J., Rao A., Sullivan E.V., Lima C.A., et al. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 24 10 (Nov-Dec 2003) 1941-1945
42. Sastre-Garriga J., Ingle G.T., Chard D.T., Ramio-Torrenta L., McLean M.A., Miller D.H., et al. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 62 4 (Apr 2005) 569-573
43. Sijens P.E., Mostert J.P., Oudkerk M., and De Keyser J. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol 16 2 (Feb 2006) 489-495
44. Tiberio M., Chard D.T., Altmann D.R., Davies G., Griffin C.M., McLean M.A., et al. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study. J Neurol 253 2 (Feb 2006) 224-230
45. Pan J.W., Hetherington H.P., Vaughan J.T., Mitchell G., Pohost G.M., and Whitaker J.N. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 36 1 (Jul 1996) 72-77
46. Staffen W., Zauner H., Mair A., Kutzelnigg A., Kapeller P., Stangl H., et al. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. J Neuropsychiatry Clin Neurosci 17 3 (Summer 2005) 357-363
47. Van Au Duong M., Audoin B., Le Fur Y., Confort-Gouny S., Malikova I., Soulier E., et al. Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS: a MRSI study. J Neurol 254 7 (Jul 2007) 914-923
48. Ferguson B., Matyszak M.K., Esiri M.M., and Perry V.H. Axonal damage in acute multiple sclerosis lesions. Brain 120 Pt 3 (Mar 1997) 393-399
49. Ginsberg S.D., and Martin L.J. Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J Neurotrauma 19 1 (Jan 2002) 99-109
50. Kovac A.D., Kwidzinski E., Heimrich B., Bittigau P., Deller T., Nitsch R., et al. Entorhinal cortex lesion in the mouse induces transsynaptic death of perforant path target neurons. Brain Pathol. 14 3 (Jul 2004) 249-257
51. Cowan W.M. Anterograde and retrograde transneuronal degeneration in the central and peripheral nervous system. In: Nauta W.J.H., and Ebbesson S. (Eds). Contemporary research methods in neuroanatomy (1970), Springer, Berlin 341-380
52. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., et al. Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci 21 16 (Aug 15 2001) 6214-6220
53. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 11 (Nov 1983) 1444-1452
54. Li D.K., Zhao G., and Paty D.W. T2 hyperintensities: findings and significance. Neuroimaging Clin N Am 10 4 (Nov 2000) 717-738 ix
55. Barkhof F., Karas G.B., and van Walderveen M.A. T1 hypointensities and axonal loss. Neuroimaging Clin N Am 10 4 (Nov 2000) 739-752 ix
56. Ordidge R.J., Mansfield P., Lohman J.A., and Prime S.B. Volume selection using gradients and selective pulses. Ann N Y Acad Sci 508 (1987) 376-385
57. Frahm J., Haase A., Hanicke W., Matthaei D., Bomsdorf H., and Helzel T. Chemical shift selective MR imaging using a whole-body magnet. Radiology 156 2 (Aug 1985) 441-444
58. De Stefano N., Narayanan S., Francis G.S., Arnaoutelis R., Tartaglia M.C., Antel J.P., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 1 (Jan 2001) 65-70
59. Sled J.G., and Pike G.B. Correction for B(1) and B(0) variations in quantitative T(2) measurements using MRI. Magn Reson Med 43 4 (Apr 2000) 589-593
60. Collins D.L., Neelin P., Peters T.M., and Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18 (1994) 192-205
61. Cohen J. A power primer. Psychol Bull 112 1 (1992) 155-159